Home › Research › Down syndrome and Alzheimer's
Allelic variability in D21S11, but not in APP or APOE, is associated with cognitive decline in Down syndrome
Farrer MJ, Crayton L, Davies GE, Oliver C, Powell J, Holland AJ, Kessling AM.. Neuroreport, 1997-05-01
Topic: Brain proteins, microglia and lab models
Plain-language summary
Genetic variation in the APOE gene and variation in chromosome 21 genotypes, including the APP locus, may influence age-associated cognitive decline in adults with Down syndrome. Molecular genetic and longitudinal neuropsychological analysis was performed for 41 unrelated Caucasian individuals (mean age 48.1 +/- 1.1 years (s.c.m.)) with free trisomy 21. Allele frequencies and genotype distributions were compared among subgroups with or without evidence of cognitive decline. Genetic variability at APOE and APP was not significantly associated with evidence of cognitive decline. However, aged individuals with Down syndrome, without evidence of cognitive decline, demonstrated unusual allelic variability at D21S11. These findings are discussed in the context of current hypotheses of Alzheimer-type dementia in Down syndrome and in the general population.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study. In 41 adults with Down syndrome, genetic variability at APOE and APP was not significantly associated with cognitive decline, while unusual allelic variability at D21S11 was seen in older individuals without decline. These findings are discussed as hypotheses and do not establish a treatment or prevention.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Farrer, M. J., Crayton, L., Davies, G. E., Oliver, C., Powell, J., Holland, A. J., et al. (1997). Allelic variability in D21S11, but not in APP or APOE, is associated with cognitive decline in Down syndrome. Neuroreport. https://doi.org/10.1097/00001756-199705060-00018
Vancouver
Farrer MJ, Crayton L, Davies GE, Oliver C, Powell J, Holland AJ, et al. Allelic variability in D21S11, but not in APP or APOE, is associated with cognitive decline in Down syndrome. Neuroreport. 1997. doi:10.1097/00001756-199705060-00018. PMID: 9189907.
BibTeX
@article{farrer1997-9189907,
author = {Farrer, M. J. and Crayton, L. and Davies, G. E. and Oliver, C. and Powell, J. and Holland, A. J. and Kessling, A. M.},
title = {{Allelic variability in D21S11, but not in APP or APOE, is associated with cognitive decline in Down syndrome}},
journal = {Neuroreport},
year = {1997},
doi = {10.1097/00001756-199705060-00018},
pmid = {9189907},
url = {https://doi.org/10.1097/00001756-199705060-00018}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.
Key findings
- Genetic variability at APOE and APP was not significantly associated with evidence of cognitive decline.
- However, aged individuals with Down syndrome, without evidence of cognitive decline, demonstrated unusual allelic variability at D21S11.
- These findings are discussed in the context of current hypotheses of Alzheimer-type dementia in Down syndrome and in the general population.
Why it matters
In 41 adults with Down syndrome, genetic variability at APOE and APP was not significantly associated with cognitive decline, while unusual allelic variability at D21S11 was seen in older individuals without decline. These findings are discussed as hypotheses and do not establish a treatment or prevention.
Study details
- Study designlongitudinal study
- Evidence strengthModerate
How this study scored 45/100
Published in a peer-reviewed journal, and it is a longitudinal study following the same people over time. Scored zero for sample size, effect reported, studied in people and randomized / blinded because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Neuroreport) |
| Journal's citation record | 2 / 4 | Neuroreport: journal h-index 242 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A longitudinal study following the same people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 1 / 5 | 1997 — older than 20 years, still counted |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 0 / 3 | No effect size reported — scores zero (not stated in the record — scored 0) |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 3 / 7 | Cited 19 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.6 citations a year over 31 year(s) since 1997 |
| Impact for its field and year | 2 / 6 | Cited 2.6× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 4 other studies in this library |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Anna M. Kessling: h-index 26 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | University of Cambridge: institution h-index 1,973 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 1 country |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 9189907) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 45 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
4 studies in the alzhub library list this one in their references.
Related studies in Down syndrome and Alzheimer's from nearby years
Also tagged “down”
527 studies in the library carry the topic tag “down”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 527 tagged studies.